The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp.

By F. Guerrero‐Romero, L. Simental‐Mendía, M. González-Ortiz, E. Martínez-Abundis, M. G. Ramos-Zavala, S. Hernández-González, O. Jacques-Camarena, M. Rodríguez-Moran. Journal of Clinical Endocrinology and Metabolism, 2010

1,829 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/cc59b8f964779986a6149d8c2ee08dfe57261c76

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Lichan Tao
2. Jia-ni Xu
3. Tingting Wang
4. Fei Hua
5. Jian Li
6. J. Souza
7. J. Pareja
8. M. J. Saad

Citations in the corpus

• Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations (2022, result): “0%) compared to the gold standard, the euglycemic-hyperinsulinaemia clamp test [11].”
• TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. (2011, methodology): “Although the coefficient of agreement and the area under the curve identified in the present study were not so elevated as demonstrated in Mexican study already published [2,3], the TyG index presented a slightly better performance in comparison with the HOMA2-IR index.”